Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein (HSIC) delivers essential healthcare products and services to dental, medical, and animal health practices worldwide. This news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives.
Track all official announcements through our curated collection of press releases and verified news coverage. Stay informed about earnings reports, product launches, partnership agreements, and operational milestones that shape Henry Schein's position in global healthcare distribution.
Key updates include acquisitions expanding service capabilities, technological innovations in supply chain management, and regulatory developments affecting medical device distribution. Our repository eliminates fragmented research by consolidating critical information from multiple sources.
Bookmark this page for efficient monitoring of HSIC's market activities. Return regularly to access new filings, leadership updates, and analysis of trends impacting healthcare providers and distributors.
Henry Schein (Nasdaq: HSIC) has launched its 16th annual Practice Pink program, raising over
BD (Becton, Dickinson and Company) has announced a grant of $360,000 to six U.S. free clinics as part of its Point-of-Care, Enhancing Clinical Effectiveness initiative. This program, established in 2017, has supported 27 clinics across 20 states with a total of $2.6 million. The initiative aims to improve health outcomes in underserved communities by providing diagnostic testing capabilities for common health issues, impacting over 16,500 patient visits this year. Collaborating partners include Heart to Heart International and the National Association of Free and Charitable Clinics.
Henry Schein, Inc. commemorated its 90th anniversary today by opening the Nasdaq Stock Market, reflecting on its founding in 1932 during the Great Depression. CEO Stanley M. Bergman emphasized the company's journey from a storefront pharmacy to a global leader serving over one million customers. Henry Schein has been a FORTUNE 500 member since 2004 and is part of the S&P 500 index since 2015. It employs over 22,000 Team Schein Members across 32 countries and has achieved $12.4 billion in sales for 2021, marking a 12.5% compound annual growth rate since going public.
Henry Schein (NASDAQ: HSIC) showcased a range of innovative dental and medical solutions at the AAOMS Annual Conference in New Orleans from September 12 to 17. The company highlighted products such as 3D printers, intraoral scanners, and anesthesia solutions, aiming to support oral and maxillofacial surgeons in enhancing patient care. Their team provided insights on customized solutions and showcased Henry Schein-brand products, promoting efficiency in surgical practices. The company emphasizes its commitment to being a trusted advisor to the OMS community.
Henry Schein, Inc. (Nasdaq: HSIC) announced the acquisition of Midway Dental Supply, enhancing its presence in the U.S. dental distribution market. The deal includes Midway Dental’s 7,000 customers and approximately
Henry Schein, Inc. (Nasdaq: HSIC), a leading provider of healthcare solutions for dental and medical practitioners, announced its participation in two key investor conferences in September 2022. The company will present at the Morgan Stanley 20th Annual Global Healthcare Conference in New York on September 12, followed by the Baird 2022 Global Healthcare Conference on September 14. Interested investors can access live webcasts of the presentations on the company's website, with replays available afterward. Henry Schein reported $12.4 billion in sales for 2021.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
